glutathione clinical trials Topical cyclodextrin complex trial study design India clinical trial to evaluate

FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables Compounding Alert: June 7, 2019 Introduction FDA warned compounders on February 1, 2019, not to use glutathione L-reduced powder (L-glutathione) distributed by Letco Medical located in Decatur, Alabama, to compound sterile injectable drugs

The lack of third-party verification, combined with extreme dose claims that exceed anything used in clinical research, made these products impossible to recommend regardless of their star ratings

Additional supplement : 10-50g 2

Further Reading and References Enjoyed this month blog